Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles F Whalen

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Anticancer Research|September 21, 2012
Cancer immunotherapy by intratumoral injection of α-gal glycolipidsGiles F Whalen, Mary Sullivan, Bilal Piperdi, et al.
The Journal of Surgical Research|May 4, 2015
Treatment of peritoneal carcinomatosis with intraperitoneal administration of Ad-hARFBarur R Rajeshkumar, Seema Paliwal, Laura Lambert, et al.
American Journal of Hypertension|May 23, 2002
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanningGeorge A Mansoor, Carl D Malchoff, Melih H Arici, et al.
Annals of Surgical Oncology|June 8, 2002
Laparoscopic resection of large adrenal tumorsDougald C MacGillivray, Giles F Whalen, Carl D Malchoff, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 10, 2009
National complication rates after pancreatectomy: beyond mere mortalityJessica P Simons, Shimul A Shah, Sing Chau Ng, et al.
Cancers|October 23, 2012
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal GlycolipidsUri Galili, Mark R Albertini, Paul M Sondel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinomaNaomi Y Jiang, Bruce A Woda, Barbara F Banner, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 3, 2016
Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resectionPei-Wen Lim, Kate H Dinh, Mary Sullivan, et al.
Journal of the American College of Surgeons|October 6, 2009
In-hospital mortality after pancreatic resection for chronic pancreatitis: population-based estimates from the nationwide inpatient sampleJoshua S Hill, James T McPhee, Giles F Whalen, et al.
Journal of Surgical Oncology|August 30, 2014
Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusionMatthew J Furman, Robert J Picotte, Mark J Wante, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Anticancer Research|September 21, 2012
Cancer immunotherapy by intratumoral injection of α-gal glycolipidsGiles F Whalen, Mary Sullivan, Bilal Piperdi, et al.
The Journal of Surgical Research|May 4, 2015
Treatment of peritoneal carcinomatosis with intraperitoneal administration of Ad-hARFBarur R Rajeshkumar, Seema Paliwal, Laura Lambert, et al.
American Journal of Hypertension|May 23, 2002
Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanningGeorge A Mansoor, Carl D Malchoff, Melih H Arici, et al.
Annals of Surgical Oncology|June 8, 2002
Laparoscopic resection of large adrenal tumorsDougald C MacGillivray, Giles F Whalen, Carl D Malchoff, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 10, 2009
National complication rates after pancreatectomy: beyond mere mortalityJessica P Simons, Shimul A Shah, Sing Chau Ng, et al.
Cancers|October 23, 2012
In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal GlycolipidsUri Galili, Mark R Albertini, Paul M Sondel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinomaNaomi Y Jiang, Bruce A Woda, Barbara F Banner, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 3, 2016
Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resectionPei-Wen Lim, Kate H Dinh, Mary Sullivan, et al.
Journal of the American College of Surgeons|October 6, 2009
In-hospital mortality after pancreatic resection for chronic pancreatitis: population-based estimates from the nationwide inpatient sampleJoshua S Hill, James T McPhee, Giles F Whalen, et al.
Journal of Surgical Oncology|August 30, 2014
Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusionMatthew J Furman, Robert J Picotte, Mark J Wante, et al.
Pageof 4